Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 180.22-67.21-38.59-

What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?

The latest EBIT Growth ratio of PIRAMAL PHARMA is 180.22 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024180.22
Mar2023-67.21
Mar2022-38.59
Mar2021-

How is EBIT Growth of PIRAMAL PHARMA Trending?

Years EBIT Growth % Change
Mar2024 180.22
Positive
Mar2023 -67.21
Negative
Mar2022 -38.59
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EBIT Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,586.9 Cr 2.9% -12.7% 57.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,569.0 Cr 2.8% -7.5% 2.3% Stock Analytics
DIVIS LABORATORIES ₹146,318.0 Cr -0.2% -9.9% 60.4% Stock Analytics
CIPLA ₹118,110.0 Cr 4.4% -0.6% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,926.0 Cr 4.8% -2.9% 15.4% Stock Analytics
DR REDDYS LABORATORIES ₹93,471.5 Cr NA -9.4% -10.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.9%

-12.7%

57.8%

SENSEX

1.4%

-5.3%

0.3%


You may also like the below Video Courses